Consensus: soy isoflavones as a first-line approach to the treatment of menopausal vasomotor complaints

Mathias SchmidtInternational Society for Phytosciences, Mattsies, Germany, Correspondence[email protected]

Karin Arjomand-WölkartInstitut Für Pharmazeutische Wissenschaften, Karl-Franzens-Universität Graz, Graz, Austria,

Martin H. BirkhäuserGynaecological Endocrinonoly and Reproductive Medicine, Medical Faculty, University of Berne, Basel, Switzerland,

Andrea R. GenazzaniDepartment of Gynaecology and Obstetrics, European Society of Gynecology, University of Pisa, Pisa, Italy,

Doris M. Gruber1st Department of Gynaeology and Obstetrics, University of Vienna, Wien, Austria,

J. Huber1st Department of Gynaeology and Obstetrics, University of Vienna, Wien, Austria,

Heinz Kölbl1st Department of Gynaeology and Obstetrics, University of Vienna, Wien, Austria,

Samo KreftChair of Pharmacognostic and Phytochemical Laboratory, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia,

Sepp Leodolter1st Department of Gynaeology and Obstetrics, University of Vienna, Wien, Austria,

Doris Linsberger1st Department of Gynaeology and Obstetrics, University of Vienna, Wien, Austria,

Markus Metka1st Department of Gynaeology and Obstetrics, University of Vienna, Wien, Austria,

Tommaso SimonciniDivision of Obstetrics and Gynadecology, Department of Clinical and Experimental Medicine, Università Di Pisa, Pisa, Italy, and

Lucija Vrabic DezmanSlovenian Menopause Society, Kranj, Slovenia

Articles from other publishers (16)